Stuart Essig - Jan 5, 2023 Form 3 Insider Report for Orthofix Medical Inc. (OFIX)

Role
Director
Signature
/s/ Patrick Keran, attorney-in-fact
Stock symbol
OFIX
Transactions as of
Jan 5, 2023
Transactions value $
$0
Form type
3
Date filed
1/9/2023, 05:38 PM
Previous filing
Jan 31, 2023
Next filing
Apr 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OFIX Common Stock 192K Jan 5, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OFIX Stock Option (right to buy) Jan 5, 2023 Common Stock 40.9K $37.67 Direct F2, F3
holding OFIX Stock Option (right to buy) Jan 5, 2023 Common Stock 2.89K $41.27 Direct F4, F5
holding OFIX Stock Option (right to buy) Jan 5, 2023 Common Stock 10.4K $24.00 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired pursuant to the terms of the merger between the Issuer and SeaSpine Holdings Corporation ("SeaSpine") which became effective on January 5, 2023 (the "Merger"), in exchange for 460,275 shares of SeaSpine, shares having a market value of $22.76 per share at the effective time of the Merger.
F2 The option vested as to 25% of the underlying shares on November 1, 2015 and the remaining 75% vested in three equal quarterly installments thereafter.
F3 The option was assumed by Issuer in connection with the Merger and replaced 98,198 SeaSpine options with an exercise price of $15.68.
F4 The option vested as to 50% of the underlying shares on February 1, 2016 and as to 25% of the underlying shares on each of May 1, 2016 and August 1, 2016.
F5 The option was assumed by Issuer in connection with the Merger and replaced 6,944 SeaSpine options with an exercise price of $17.18.
F6 The option vested in four equal installments on each of September 7, 2016, December 7, 2016, March 7, 2017 and June 7, 2017.
F7 The option was assumed by Issuer in connection with the Merger and replaced 25,056 SeaSpine options with an exercise price of $9.99.